Evolving and Emerging Trends in HER2 Classification and Reporting in Breast Cancer

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

#BREASTPATH Destiny of HER2/neu in the era of HER2-low in 2024Подробнее

The evolution of HER2-low-positive breast cancer as a clinical subtypeПодробнее

New Perspectives on the Full Spectrum of HER2 Expression in Breast CancerПодробнее

Evolving Landscape of HER2-Targeted Therapy in Breast CancerПодробнее

#ESMO21 Expert Video Report on HER2-positive metastatic breast cancerПодробнее

The evolution of HER2 targeting in metastatic breast breast cancerПодробнее

The evolution of HER2-low breast cancer from primary to recurrenceПодробнее

Treatment Updated for HER2 Positive Breast Cancer: Changing ParadigmsПодробнее

New technology improves breast cancer treatmentПодробнее

A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast CancerПодробнее

The Science of HER2-low Breast Cancer and Implications for the Pathology TeamПодробнее

HER2 IHC Interpretation Guide (Examples and Challenging Scenarios)Подробнее

Evolving Role of HER2-Targeted Therapy in Breast CancerПодробнее

The evolution of advanced breast cancer managementПодробнее

Biological behaviour of HER2-low BC is dependent on HR expressionПодробнее

New and emerging agents in HER2-negative metastatic breast cancer: Implications for practiceПодробнее

Dr. Sunil Verma on the Evolution of Treatment in HER2-Positive Breast CancerПодробнее